AAMI/FDA Announce Infusion Pump SummitAAMI/FDA Announce Infusion Pump Summit
AAMI and FDA have announced a groundbreaking summit aimed at improving the safety of infusion pumps. The summit is scheduled take place Oct. 5-6 at FDA headquarters in Silver Spring, MD.Now is the time to have your voice heard in this unprecedented effort to build a consensus and find constructive solutions to one of the top concerns in the healthcare community.
August 3, 2010
Infusion pumps are among the most widely used medical devices in today's healthcare system. Yet, between 2005 and 2009, FDA has received approximately 56,000 adverse events associated with their use.
This summit will be open to individuals and organizations that have a key interest in the improvement of these devices and in patient safety. Expected participants include:
Hospital and industry senior executives
Design engineers
Researchers and developers of drug delivery devices
Academicians
Pharmacists
Nurses
Surgical technologists
Human factors engineers
Clinical engineers
Biomedical equipment technologists
Quality system and standards compliance managers
Risk managers
The summit will bring together key stakeholders to develop concrete action plans that will improve the design, engineering, manufacturing, and use of infusion pumps—including data collection, user interface, safety standards, insulin infusion, and human factors.
In support of the summit, the following organizations will work with AAMI and FDA to build awareness among their constituents and memberships about the event:
Association of periOperative Registered Nurses (AORN)
Center for Integration of Medicine and Innovative Technology (CIMIT)
Parenteral Drug Association (PDA)
Association of Surgical Technologists (AST)
Registration is required.
For more information about the summit, including the agenda and hotel information, click here.
Â
You May Also Like